PA
SXT icon

PharVision Advisers’s Sensient Technologies SXT Stock Holding History

PharVision Advisers’s Portfolio SXT Stock Details SXT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,242
Closed -$304K – 991
2025
Q3 		$304K Buy
+3,242
New +$355K 0.17% 219

Other funds holding SXT

FC
Freemont Capital Singapore $4.9B AUM 11.61% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.3B AUM 29.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return

PharVision Advisers's SXT Position: Q4 2025 in Review

PharVision Advisers sold out of Sensient Technologies (SXT) in Q4 2025, closing a stake of 3,242 shares — an estimated $304K sold.

PharVision Advisers first reported a position in SXT in Q3 2025 and held it in 1 quarter. The position peaked at $304K in Q3 2025. 347 funds tracked by Wall St. Rank hold SXT as of Q4 2025.

  • PharVision Advisers reported no remaining Sensient Technologies position as of Q4 2025 after selling out during the quarter.
  • PharVision Advisers sold 3,242 Sensient Technologies shares in Q4 2025, an estimated $304K.
  • PharVision Advisers first reported a position in Sensient Technologies in Q3 2025 and held it in 1 quarter.
  • PharVision Advisers's Sensient Technologies position peaked at $304K in Q3 2025.
  • 347 funds tracked by Wall St. Rank held Sensient Technologies as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.